EGFR and cancer: Here we exploit the multiplexing capabilities of Exchange-PAINT, a multiplexed variant of DNA-PAINT14, to image simultaneously five RTKs (EGFR, ErbB2, ErbB3, IGF-1R and Met) at endogenous levels of expression in BT20 cancer cells and to examine how receptor distribution changes following ligand stimulation.